Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients

Journal of the American Geriatrics Society

Volumn 56, Issue 7, 2008, Pages 1183-1190

  Brown, Sydney E S ^a   Meltzer, David O ^b   Chin, Marshall H ^b   Huang, Elbert S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aging; Diabetes mellitus; Patient preferences; Quality of life; Treatments

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOLIC ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DEATH; DIET THERAPY; DISEASE DURATION; FEMALE; HEALTH CENTER; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PILL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE;

AGED; CHICAGO; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 48449107176     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01757.x     Document Type: Article

References (47)

1. Standards of medical care in diabetes-2007. Diabetes Care 2007 30 (Suppl 1) : S4 S41.
2. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003 289 : 2560 2572.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 (19) : 2486 2497.
4. Nathan DM, Singer DE, Godine JE et al. Retinopathy in older type 2 diabetics: Association with glucose control. Diabetes 1986 35 : 797 801.
5. Nathan DM, Meigs JB, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is... or is it? Lancet 1997 350 (Suppl 1) : SI4 SI9.
6. Kuller LH. Stroke and diabetes. In : Harris MI, ed. Diabetes in America, 2nd Ed. Bethesda : National Institutes of Health, 1995, pp 449 456.
7. Turner RC, Cull CA, Frighi V et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK prospective diabetes study (UKPDS) group. JAMA 1999 281 : 2005 2012.
8. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003 348 : 383 393.
9. U.K. Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
10. Shorr RI, Ray WA, Daugherty JR et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997 157 : 1681 1686.
11. Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003 348 : 42 49.
12. Vijan S, Hayward RA, Ronis DL et al. The burden of diabetes therapy: Implications for the design of effective patient-centered treatment regimens. J Gen Intern Med 2005 20 : 479 482.
13. Huang ES, Brown SE, Ewigman BG et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007 30 : 2478 2483.
14. Huang ES, Jin L, Shook M et al. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new onset diabetes. Diabetes Care 2006 29 : 259 264.
15. Huang ES, Gorawara-Bhat R, Chin MH. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005 53 : 306 311.
16. Huang ES. Goal setting in older adults with diabetes. In : Munshi MN, Lipsitz LA, eds. Geriatric Diabetes. New York : Informa Healthcare USA, 2007.
17. Brown AF, Mangione CM, Saliba D et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003 51 (5 Suppl) : S265 S280.
18. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004 27 (Suppl 1) : S15 S35.
19. Saliba D, Elliott M, Rubenstein LV et al. The vulnerable elders survey: A tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001 49 : 1691 1699.
20. Huang ES, Gorawara-Bhat R, Chin MH. Practical challenges of individualizing diabetes care in older patients. Diabetes Educ 2004 30 : 558 570.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 : 189 198.
22. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in healthcare. Annu Rev Public Health 2000 21 : 587 611.
23. Russell LB, Gold MR, Siegel JE et al. The role of cost-effectiveness analysis in health and medicine. JAMA 1996 276 : 1172 1177.
24. U.K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998 317 : 703 713.
25. Gage BF, Cardinalli AB, Owens DK. Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation. Stroke 1998 29 : 1083 1091.
26. Downs JR, Clearfield M, Weis S et al. Coronary events with lipid-lowering therapy: The AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherolsclerosis Prevention Study. JAMA 1998 279 : 1615 1622.
27. Prosser LA, Stinnett AA, Goldman PA et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 2000 132 : 769 779.
28. Grover S, Paquet S, Levington C et al. Estimating the benefits of modifying risk factors of cardiovascular disease: A comparison of primary vs. secondary prevention. Arch Intern Med 1998 158 : 655 662.
29. Goldman L, Coxson PG, Hunink MGM et al. The relative influence of secondary versus primary prevention using the national cholesterol education program adult treatment panel II guidelines. J Am Coll Cardiol 1999 34 : 768 776.
30. Ganz DA, Kuntz KM, Jacobson GA et al. Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med 2000 132 : 780 787.
31. Reader D, Carstensen K. Five Good Food Habits for People with Diabetes. Minneapolis, MN : International Diabetes Center, Park Nicollet Medical Foundation, 1995.
32. Franz MJ, Bantle JP, Beebe CA et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003 26 (Suppl 1) : S51 S61.
33. Zinman B, Ruderman N, Campaigne BN et al. Physical activity/exercise and diabetes mellitus. Diabetes Care 2003 26 (Suppl 1) : S73 S77.
34. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003 326 : 1419 1423.
35. Ware JEJ, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales, 2nd Ed. Boston, MA : The Health Institute, New England Medical Center, 1995.
36. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 383.
37. Min LC, Elliott MN, Wenger NS et al. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc 2006 54 : 507 511.
38. Lee SJ, Lindquist K, Segal MR et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006 295 : 801 808.
39. Gazmararian JA, Baker DW, Williams MV et al. Health literacy among medicare enrollees in a managed care organization. JAMA 1999 281 : 545 551.
40. Tseng CW, Tierney E, Gerzoff RB et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes. The Translating Research Into Action for Diabetes Study. Diabetes Care 2008 31 : 261 266.
41. Peek ME, Chin MH. Care of community-living racial/ethnic minority elders. In : Munshi MN, Lipsitz LA, eds. Geriatric Diabetes. New York : Informa Healthcare, 2007, pp 357 376.
42. Royall DR. Mild cognitive impairment and functional status. J Am Geriatr Soc 2006 54 : 163 165.
43. Royall DR, Palmer R, Chiodo LK et al. Executive control mediates memory's association with change in instrumental activities of daily living: The freedom house study. J Am Geriatr Soc 2005 53 : 11 17.
44. Montori VM, Gafni A, Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: The case of diabetes. Health Expect 2006 9 : 25 36.
45. Huang ES, Sachs GA, Chin MH. Implications of new geriatric diabetes care guidelines for the assessment of quality of care in older patients. Med Care 2006 44 : 373 377.
46. Epstein AM. Pay for performance at the tipping point. N Engl J Med 2007 356 : 515 517.
47. Boyd CM, Darer J, Boult C et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005 294 : 716 724.